Literature DB >> 23966293

Integrin αvβ3 and fibronectin upregulate Slug in cancer cells to promote clot invasion and metastasis.

Lynn M Knowles1, Lisa A Gurski, Charlotte Engel, James R Gnarra, Jodi K Maranchie, Jan Pilch.   

Abstract

The blood clotting cascade is selectively involved in lung metastasis, but the reason for this selectivity is unclear. Here, we show that tumor cells that metastasize predominantly to the lung, such as renal cell carcinoma (RCC) and soft tissue sarcoma (STS), have an inherent capacity to generate extensive invadopodia when embedded in a blood clot. Compared with other metastatic cancer cells tested, RCC and STS cells exhibited increased levels of expression of fibronectin and an activated form of the integrin αvβ3, which coordinately supported the generation of an elaborate fibronectin matrix and actin stress fibers in fibrin-embedded tumor cells. Together, fibronectin and αvβ3 induced upregulation of the transcription factor Slug, which mediates epithelial-mesenchymal transition as well as fibrin invasion and lung metastasis. This mechanism is clinically significant, because primary cancer cells from patients with metastatic RCC strongly invaded fibrin and this correlated with fibronectin matrix formation and Slug expression. In contrast, tumor cells from patients with localized RCC were largely noninvasive. Together, our findings establish that activated integrin αvβ3 and fibronectin promote lung metastasis by upregulating Slug, defining a mechanism through which cancer cells can colonize blood clots in the lung vasculature. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23966293      PMCID: PMC3837455          DOI: 10.1158/0008-5472.CAN-13-0602

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling.

Authors:  Egle Avizienyte; Anne W Wyke; Robert J Jones; Gordon W McLean; M Andrew Westhoff; Valerie G Brunton; Margaret C Frame
Journal:  Nat Cell Biol       Date:  2002-08       Impact factor: 28.824

2.  Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion.

Authors:  Gunjan Malik; Lynn M Knowles; Rajiv Dhir; Shuping Xu; Shuting Yang; Erkki Ruoslahti; Jan Pilch
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

3.  Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation.

Authors:  Jae Hong Im; Weili Fu; Hui Wang; Sujata K Bhatia; Daniel A Hammer; M Anna Kowalska; Ruth J Muschel
Journal:  Cancer Res       Date:  2004-12-01       Impact factor: 12.701

Review 4.  A perspective on cancer cell metastasis.

Authors:  Christine L Chaffer; Robert A Weinberg
Journal:  Science       Date:  2011-03-25       Impact factor: 47.728

5.  Genomic analysis of metastasis reveals an essential role for RhoC.

Authors:  E A Clark; T R Golub; E S Lander; R O Hynes
Journal:  Nature       Date:  2000-08-03       Impact factor: 49.962

6.  Canonical Wnt signaling regulates Slug activity and links epithelial-mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repression.

Authors:  Zhao-Qiu Wu; Xiao-Yan Li; Casey Yuexian Hu; Michael Ford; Celina G Kleer; Stephen J Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-24       Impact factor: 11.205

7.  Regulation of fibronectin matrix assembly by activated Ras in transformed cells.

Authors:  K A Brenner; S A Corbett; J E Schwarzbauer
Journal:  Oncogene       Date:  2000-06-29       Impact factor: 9.867

8.  Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis.

Authors:  Brunhilde Felding-Habermann; Richard A Lerner; Antonietta Lillo; Shufei Zhuang; Martin R Weber; Sandra Arrues; Changshou Gao; Shenlan Mao; Alan Saven; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

9.  Activation of Rap1 promotes prostate cancer metastasis.

Authors:  Candice L Bailey; Patrick Kelly; Patrick J Casey
Journal:  Cancer Res       Date:  2009-05-26       Impact factor: 12.701

10.  Differential expression of prognostic proteomic markers in primary tumour, venous tumour thrombus and metastatic renal cell cancer tissue and correlation with patient outcome.

Authors:  Alexander Laird; Fiach C O'Mahony; Jyoti Nanda; Antony C P Riddick; Marie O'Donnell; David J Harrison; Grant D Stewart
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

View more
  46 in total

1.  A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.

Authors:  Zhuxian Zhou; Zhen Han; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

Review 2.  The Two Faces of Adjuvant Glucocorticoid Treatment in Ovarian Cancer.

Authors:  Vladimir Djedovic; Yoo-Young Lee; Alexandra Kollara; Taymaa May; Theodore J Brown
Journal:  Horm Cancer       Date:  2018-01-08       Impact factor: 3.869

3.  Transient mechanical strain promotes the maturation of invadopodia and enhances cancer cell invasion in vitro.

Authors:  Alexander N Gasparski; Snehal Ozarkar; Karen A Beningo
Journal:  J Cell Sci       Date:  2017-04-26       Impact factor: 5.285

Review 4.  The evolving relationship of wound healing and tumor stroma.

Authors:  Deshka S Foster; R Ellen Jones; Ryan C Ransom; Michael T Longaker; Jeffrey A Norton
Journal:  JCI Insight       Date:  2018-09-20

5.  Resistance to the mTOR inhibitor temsirolimus alters adhesion and migration behavior of renal cell carcinoma cells through an integrin α5- and integrin β3-dependent mechanism.

Authors:  Eva Juengel; Jasmina Makarević; Michael Reiter; Jens Mani; Igor Tsaur; Georg Bartsch; Axel Haferkamp; Roman A Blaheta
Journal:  Neoplasia       Date:  2014-04       Impact factor: 5.715

6.  Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling.

Authors:  Jianjun Han; Lu Zhang; Hui Guo; Weiya Z Wysham; Dario R Roque; Adam K Willson; Xiugui Sheng; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Gynecol Oncol       Date:  2015-06-30       Impact factor: 5.482

7.  Hypoxia stimulates invasion and migration of human cervical cancer cell lines HeLa/SiHa through the Rab11 trafficking of integrin αvβ3/FAK/PI3K pathway-mediated Rac1 activation.

Authors:  Hao Xu; Yuan Yuan; Wenqian Wu; Min Zhou; Qian Jiang; Linjun Niu; Jiayin Ji; Nianli Liu; Longzhen Zhang; Xia Wang
Journal:  J Biosci       Date:  2017-09       Impact factor: 1.826

8.  The Interplay Between Epithelial-Mesenchymal Transition (EMT) and the Thyroid Hormones-αvβ3 Axis in Ovarian Cancer.

Authors:  Chen Weingarten; Yonatan Jenudi; Rami Yair Tshuva; Dotan Moskovich; Adi Alfandari; Aleck Hercbergs; Paul J Davis; Martin Ellis; Osnat Ashur-Fabian
Journal:  Horm Cancer       Date:  2017-12-19       Impact factor: 3.869

9.  Sarcoma Tumor Microenvironment.

Authors:  Panagiotis Tsagozis; Jordi Gonzalez-Molina; Anna-Maria Georgoudaki; Kaisa Lehti; Joseph Carlson; Andreas Lundqvist; Felix Haglund; Monika Ehnman
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.

Authors:  Laetitia Seguin; Shumei Kato; Aleksandra Franovic; M Fernanda Camargo; Jacqueline Lesperance; Kathryn C Elliott; Mayra Yebra; Ainhoa Mielgo; Andrew M Lowy; Hatim Husain; Tina Cascone; Lixia Diao; Jing Wang; Ignacio I Wistuba; John V Heymach; Scott M Lippman; Jay S Desgrosellier; Sudarshan Anand; Sara M Weis; David A Cheresh
Journal:  Nat Cell Biol       Date:  2014-04-20       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.